Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoi…

Drug Manufacturers - Specialty & Generic

US, Ann Arbor [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Mergers & Acquisitions Beta

M&As

ESPR M&As
Drug Manufacturers - Specialty & Generic M&A

M&A Deals · Breakdown

Esperion Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Esperion Therapeutics, Inc. has no acquisition track records yet.